IVOI

[evgeny05]

Hi
These are the latest news which I have found


iVoice Announces Additional Plans To Enter Alternative Energy Sector; Company Targets Acquisition of Promising Biodiesel Technology 
Tuesday , June 20, 2006 08:00 ET
MATAWAN, N.J., Jun 20, 2006 (BUSINESS WIRE) -- iVoice, Inc. (OTC Bulletin Board: IVOI), a developer and licensor of proprietary technologies, announced today additional plans to enter the alternative energy sector. The Company is currently in final negotiations to acquire a company that will own the rights to biodiesel technology, the fastest growing alternative fuel in America. iVoice will hold a majority interest in the new venture permitting it to consolidate the performance of these operations for financial reporting purposes.. The new venture, which is attempting to acquire a location in the southeastern U.S. to locate the biodiesel facility, has already received indications that a customer would enter into a contract to purchase the biodiesel, as soon as the facility is in commercial production.
"We are excited to be in the final stages of securing the technology and a suitable location to build a biodiesel plant," said iVoice Chairman and CEO Jerry Mahoney. "With energy prices near record levels, companies are increasingly turning to alternative energy providers to develop solutions. We are pleased that in a short period of time we will be in position to contribute to the country's efforts to secure a reliable alternative source of energy."
Biodiesel is a cleaner burning fuel that can be made from domestic renewable resources such as soybean oil. The alternative fuel can be used in any diesel engine with few or no modifications, in pure form or blended with petroleum diesel at any level. Biodiesel significantly reduces emissions while offering similar performance to diesel. Today, about 600 major fleets use biodiesel nationwide. More than 700 retail filling stations make various biodiesel blends available to the public, and 1,600 petroleum distributors carry it nationwide.


  iVoice's Thomas Pharmaceuticals Ltd. Enters into Agreement with Bellco Drug Corp.; Leading Distributor of Pharmaceutical Products to Distribute Acid + All Product Lines
Tuesday , June 27, 2006 09:38 ET
MATAWAN, N.J., Jun 27, 2006 (BUSINESS WIRE) -- Thomas Pharmaceuticals Ltd, a wholly owned subsidiary of iVoice, Inc. (OTCBB:IVOI), announced today that it has entered into an agreement with Bellco Drug Corp. (BDC), a full-service wholesales distributor of over 20,000 branded, generic, biotech pharmaceuticals, vaccines and health and beauty care products, to distribute its Acid + All(TM) product lines. Founded in 1955, BDC distributes to independent and chain retail pharmacies, government agencies, and an array of institutional pharmacy markets. Acid + All(TM) is changing the over-the-counter pharmaceutical category by offering a highly effective pharmaceutical product within an attractive packaging.
Through two state-of-the-art distribution facilities located in N. Amityville, New York and Brea, California, BDC is strategically positioned to provide rapid, accurate, and economical delivery service to customers throughout the United States. BDC has long-term, multi-level relationships with every major pharmaceutical and HBC manufacturer, which fosters co-marketing initiatives that benefit customers. BDC is also an accredited member of the Healthcare Distribution Management Association (HDMA) and a member of the Generic Pharmaceutical Association (GPhA).
"In the short time since we launched the product, we have secured distribution with several leading drugstore chains and distributors to independent drugstores, reflecting the strong interest in the product," said Mr. Thomas, President and Founder of Thomas Pharmaceuticals Ltd. "Our goal is to have the provide available for consumers in all of the leading independent and major pharmacy chains."
Acid + All(TM), the calcium enriched, spearmint-flavored, sugar free tablets that soothe heartburn, acid indigestion and gas is available at independent pharmacies, major drug chains and online retailers or by calling toll-free at 1-888-922-1959. Acid + All(TM) will be available in a sleek, 32-count pillbox and will retail for approximately $3.89. Thomas Pharmaceutical plans to introduce Acid + All(TM) line extensions later this year along with other new over-the-counter products. For more information about Acid + All(TM) go to www.acidall.com


Support 0.06$

[setravis]

Interesting to say the least, evgeny05
Nice little gainer yesterday.
Let's see if we get some follow through.

Recent CandleStick Analysis
Neutral
Jun-29-2006 Bullish Engulfing 
Yesterday's Candlestick Patterns:
White Closing Marubozu
Today a White Closing Marubozu was formed. This shows that the day opened and then prices went lower slightly, however it was followed by a rally that drove the prices over the opening price and the rally continued all day ending with a closing price equal to the high of the day.

Stochastic is Bullish
Support @ 0.08...0.06
Resistance @ 0.09...0.10...0.12

[evgeny05]

Hi
If IVOI will break resistance at 0.09 it is possible to buy (only my opinion) 

[evgeny05]

Hi


iVoice's Thomas Pharmaceuticals Ltd. Receives Order From Rite Aid Corporation; Acid + All Product Line To Be Sold in More Than 3,300 Stores of Leading Drug Chain
Business Wire - July 11, 2006 08:00

MATAWAN, N.J., Jul 11, 2006 (BUSINESS WIRE) -- Thomas Pharmaceuticals Ltd, a wholly owned subsidiary of iVoice, Inc. (OTCBB:IVOI), announced today that it has received from Rite Aid Corporation, one of the nation's leading drugstore chains, a stocking order for its smartly packaged and marketed new upscale antacid tablet product line Acid + All(TM). Acid + All(TM) is changing the over-the-counter pharmaceutical category by offering a highly effective pharmaceutical product within an attractive packaging. The product will be sold in more than 3,300 Rite Aid stores in 27 states using a special display carton developed by Thomas at Rite Aid's request.

"We continue to attract leading independent and major pharmacy chains seeking to offer the Acid + All product line," said Tom Thomas, President and Founder of Thomas Pharmaceuticals Ltd. "This agreement with Rite Aid will significantly broaden our distribution in many of the major markets we target."

Acid + All(TM), the calcium enriched, spearmint-flavored, sugar free tablets that soothe heartburn, acid indigestion and gas is available at independent pharmacies, major drug chains and online retailers or by calling toll-free at 1-888-922-1959. Acid + All(TM) will be available in a sleek, 32-count pillbox and will retail for approximately $3.89. Thomas Pharmaceuticals Ltd. plans to introduce Acid + All(TM) line extensions later this year along with other new over-the-counter products. For more information about Acid + All(TM) go to www.acidall.com

[evgeny05]

Volume + + +
Probably morning news will advance IVOI , I buy (only my opinion)

[evgeny05]

Hi
http://www.stockta.com/cgi-bin/analysis.pl?symb=IVOI&num1=2&cobrand=TV&mode=stock

[evgeny05]

Hi
IVOI support 0.007 and 0.006.

[evgeny05]

 

[evgeny05]

Hi

[evgeny05]

 

[evgeny05]

Hi

[evgeny05]

Hi

[evgeny05]

Hi



iVoice Subsidiary Secures Rights to Land For Company's First Anticipated Biodiesel Facility
By BusinessWire
Last Update: 7/25/2006 8:30:04 AM Data provided by 

MATAWAN, N.J., Jul 25, 2006 (BUSINESS WIRE) -- iVoice, Inc. (IVOI), a developer and licensor of proprietary technologies, announced today that iVoice Innovations, Inc., a wholly-owned subsidiary of iVoice, has entered into an Option Agreement to acquire four acres of land in Hanover County, Virginia, approximately 20 miles from Richmond, Virginia, together with all improvements, easements, water rights, mineral rights and other structures for a total cost of $800,000. The transaction is expected to close during the third quarter or fourth quarter 2006. The Company plans to use the location as the site of a proposed new biodiesel facility. iVoice recently announced it had authorized a non-binding Letter of Intent to acquire the rights to develop biodiesel technology, the fastest growing alternative fuel in America.

The Company plans to immediately commence a study to determine the scope and feasibility of the project. Upon completion of the study, engineering, design and permitting issues will be assessed in order to facilitate completion. The facility is also subject to regulatory permitting for use of producing biodiesel at the facility. The Company is currently in discussions with potential partners, who could share in the development costs and provide additional expertise.

"We are pleased that we have been able to conclude negotiations on such an ideal location for a new facility," said iVoice Chairman and CEO Jerry Mahoney. "This site is strategically located close to customers who could use our biodiesel technology and ideal for the size of project we contemplate."

Biodiesel is a cleaner burning fuel that can be made from domestic renewable resources such as soybean oil. The alternative fuel can be used in any diesel engine with few or no modifications, in pure form or blended with petroleum diesel at any level. Biodiesel significantly reduces emissions while offering similar performance to diesel. Today, about 600 major fleets use biodiesel nationwide. More than 700 retail filling stations make various biodiesel blends available to the public, and 1,600 petroleum distributors carry it nationwide

[evgeny05]

Hi

http://americanbulls.com/StockPage.asp?CompanyTicker=IVOI&MarketTicker=OTC&TYP=S

[evgeny05]

 

iVoice Completes Sale of Selected Patents; Proceeds of Transaction to Be Used to Repay Company Indebtedness
Business Wire - July 31, 2006 08:00

MATAWAN, N.J., Jul 31, 2006 (BUSINESS WIRE) -- iVoice, Inc. (OTCBB: IVOI), announced today that it has completed the sale of certain United States Letters Patents and/or applications for United States Letters Patents and/or foreign patents and applications to Lamson Holdings LLC. The patents and/or patent applications sold relate to various Voice Activated/Voice Responsive systems developed by iVoice, including item locators for retail stores utilizing various unique identifying, data gathering and organizing, as well as user feedback techniques.

Proceeds from the sale will be used to pay down some of the Company's indebtedness to Cornell Capital after paying a commission to GlynnTech, Inc. which served as iVoice's licensing agent and assisted in the sale of the patents.

"The sale of certain assets of our intellectual property demonstrates the significant value we have created in our portfolio of technologies," said iVoice Chairman and CEO Jerry Mahoney. "We will continue to seek ways to maximize shareholder value through the development of technologies that are core to our business strategy and sell or those license those technologies that we choose not to pursue."